Cell surface CD28 levels define four CD4+ T cell subsets: Abnormal expression in rheumatoid arthritis

Clinical Immunology and Immunopathology

Volumn 99, Issue 2, 2001, Pages 253-265

  Salazar Fontana, Laura Inés ^a   Sanz, Eva ^a   Mérida, Isabel ^d   Zea, Antonio ^a   Sanchez Atrio, Ana ^a   Villa, Luis ^a,b   Martínez A, Carlos ^d   De La Hera, Antonio ^a,c   Alvarez Mon, Melchor ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

B7; CD152; CD28 surface modulation; CD80; CD86; Costimulatory molecules; CTLA 4; Rheumatoid arthritis; T cell anergy

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; PRIMER DNA;

ARTICLE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ANTIGENS, CD28; ANTIGENS, CD45; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS; UP-REGULATION;

EID: 0035867978     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5003     Document Type: Article

References (20)

1. Jenkins, M. K., and Schwartz, R. H., Antigen-presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165, 302-319, 1987.
2. June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B., The B7 and CD28 receptor families. Immunol. Today 15, 321-331, 1994.
3. Linsley, P. S., Brady, W., Grossmaire, L., Arufo, A., Damle, N. K., and Ledbetter, J. A., Binding of the B cell activation antigen to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173, 721-730, 1991.
4. Lindsten, T., June, C. H., Ledbetter, J. A., Stella, G., and Thompson, C. B., Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244, 339-343, 1989.
5. Viola, A., and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104-106, 1996.
6. Hara, T., Fu, S. M., and Hansen, J. A., Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 161, 1513-1524, 1985.
7. Harper, K., Balzano, C., Rouvier, E., Mattéi, M. G., Luciani, M. F., and Goldstein, P., CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147, 1037-1044, 1991.
8. Chambers, C. A., Krummel, M. F., Boitel, B., Hurwitz, A., Sullivan, T. J., Fournier, S., Cassel, D., Brunner, M., and Allison, J. P., The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 153, 27-46, 1996.
9. Guerder, S., Picarella, D. E., Linsley, P. S., and Flavell, R. A., Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 5138-5142, 1994.
10. Finck, B. K., Linsley, P. S., and Wofsy, D., Treatment of murine lupus with CTLA4-Ig. Science 265, 1225-1227, 1994.
11. Tada, Y., Nagasawa, K., Ho, A., Morito, F., Ushiyama, O., Suzuki, N., Ohta, H., and Mak, T., CD28-deficient mice are highly resistant to collagen-induced arthritis. J. Immunol. 162, 203-208, 1999.
12. Miller, S. D., Vanderlugh, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., del Canto, M. C., and Bluestone, J. A., Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3, 739-745, 1995.
13. Karandikar, N. J., Vanderlugh, C. L., Walunas, T. L., Miller, S. D., and Bluestone, J. A., CTLA-4 a negative regulator of autoimmune disease. J. Exp. Med. 184, 783-788, 1996.
14. Kroemer, G., and Martínez-A, C., The fail-safe paradigm of immunological self-tolerance. Lancet 338, 1246-1249, 1991.
15. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., and Luthra, H. S., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 1637-1646, 1988.
16. Ranheim, E. A., and Kipps, T. J., Elevated expression of CD80(B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. Arthritis Rheum. 37, 1637-1646, 1994.
17. Finals, R. S., Baum, J., Bland, J., Fosdick, W. M., Kaplan, S. B., Masi, A. T., Mitchell, D. M., Ropes, M. W., Short, C. L., Sigler, J. W., and Weinberger, H. J., Preliminary criteria for clinical remission in rheumatoid arthritis. Bull. Rheum. Dis. 32, 7-10, 1982.
18. Sanders, M. E., Makgoba, M. W., Sharrow, S. O., Stephany, D., Springer, T. A., Young, H. A., and Shaw, S., Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, LFA-1) and three other molecules (UCHL1, CDw29, Pgp-1) and have enhanced IFN-gamma production. J. Immunol. 140, 1401-1407, 1988.
19. Springer, T. A., Adhesion receptors of the immune system. Nature 346, 425-434, 1990.
20. Sprent, J., T and B memory cells. Cell 76, 315-322, 1994.